30th Anniversary of Spheripol Process Technology celebrated at Braskem’s Neal, West Virginia Production Facility

Braskem Spheripol Process TechnologyBraskem, the leading producer of biopolymers in the world and the largest thermoplastic polyolefins producer in the Americas celebrated the 30th anniversary of the Spheripol process technology at its Neal production plant, located in the city of Kenova, West Virginia.

Spheripol process technology developed first in the U.S. is one of the most widely used PP production processes worldwide.

“On behalf of the entire Braskem team, we are proud to celebrate the 30th Anniversary of the Neal production facility taking a leadership role by bringing leading-edge innovation to the market with the first U.S. Spheripol process technology deployment ever”, said, Jeff Blatt, Plant Manager at Braskem’s Neal facility. He, added, “Our track record for success in producing polypropylene in Neal has been a key part of Braskem’s leadership position as the largest producer of polypropylene in the Americas.”

Blatt, concluded, “Since the initial launch of the Spheripol production process at Neal, the annual production capacity of the plant has almost doubled. Over the past 8 years, Braskem has invested more than $20 million in Neal, West Virginia production facility infrastructure enhancements, helping extend our successful track record for plant safety, reliability, efficiency and environmental protection.”

Braskem is committed to improving people’s lives by creating sustainable solutions with chemicals and plastics and creates more environmental-friendly, intelligent and sustainable solutions. Braskem exports to approximately 100 countries and operates 41 industrial units located in Brazil, United States, Germany and Mexico, the latter in partnership with the Mexican company Idesa.

Braskem America, an indirect wholly owned subsidiary of Braskem S.A. headquartered in Philadelphia has six production plants located in Texas, Pennsylvania and West Virginia, an Innovation and Technology Center in Pittsburgh, and a new operation in Boston.

scroll to top